P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST-LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2023-08-01
|
| Schriftenreihe: | HemaSphere |
| Online-Zugang: | http://journals.lww.com/10.1097/01.HS9.0000969496.68553.26 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
